Please login to the form below

Not currently logged in
Email:
Password:

INC Research expands Asian presence with South Korea facility

New Seoul office will focus on study start-up and clinical operations

INC Research has expanded its Asian operations, opening a new office in Seoul that will focus on study start-up and clinical operation activities.

It will be managed by Dr Jessica Liu, general manager, and Lee Sun-Mee, associate director of clinical operations and site head for South Korea, and concentrate on increasing access to patients and improving clinical trial efficiency.

The contract research organisation's (CRO) move was prompted by government efforts that have seen infrastructure improvements, including the setting up of centres of excellence for clinical trials, and a streamlining of regulatory pathways.

Kelvin Logan, president Asia/Pacific at INC Research, said: "The South Korean government has renewed its focus on healthcare and clinical development leading to a dramatic increase in the opportunities for biopharmaceutical companies' drug development programmes.

"Our expanded team is equipped to help customers take advantage of the benefits of conducting clinical trials in this region, while navigating through the developing regulatory environment and leveraging support resources."

The country's pharmaceutical market has seen five years of double-digit growth and South Korea is considered the fastest-growing developed country by IMS Health.

Although healthcare spending in general is low compared to other OECD nations, pharma expenditure is around 24 per cent of the total national health insurance system's bill.

The new office adds to INC Research's existing bases across Asia in countries such as China, India, the Philippines and Thailand.

17th September 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics